Women's Health

WHIS US

September 17 – 19, 2024 Boston, Massachusetts Premier Research invites you to the Women’s Health Innovation Summit, advancing healthcare for women worldwide. Explore cutting-edge advancements, collaborate with industry leaders, and drive actionable strategies.

WHIS Europe

April 16 – 17, 2024 Basel, Switzerland Connect with Premier Research at the WHIS event! Don’t miss the chance to engage with industry leaders and be part of insightful discussions. See you there!

Reproductive Health Innovation Summit

February 13 – 14, 2024 Boston, MA Join Premier Research at the Reproductive Health Innovation Summit, where industry c-suite professionals gather to showcase disruptive innovations, forge critical partnerships, and drive growth in reproductive health. We invite you to attend our presentation for valuable insights. Additionally, we would appreciate the opportunity to set up a meeting...

Clinical Research: Phase 1 - Phase 4

Addressing Challenges in Bringing Male Contraceptives to Market

There are currently more than a dozen categories of female birth control with proven efficacy on the market. Conversely, the only options available for men today are condoms and vasectomy, despite decades of research. No new male contraceptive products have entered the market since the condom was created in the 1800s. This is in part...

Clinical Research: Phase 1 - Phase 4

Considerations for Clinical Studies in Contraception

Women today can choose from a wide range of effective and safe contraceptives based on their medical and lifestyle needs. Over the course of their lives, women may change contraceptive methods for a variety of reasons, such as concerns about side effects. For researchers, the objective of contraceptive development is to design products that offer...

Clinical Research: Phase 1 - Phase 4

Addressing the Challenges and Opportunities in Gynecologic Cancer Research

Gynecologic cancers continue to be a significant cause of female morbidities and mortality worldwide. Significant unmet needs exist in diagnosis and treatment. These cancers are often detected at later stages when therapeutic options are limited, and advanced or recurrent disease leads to a poor prognosis. Earlier diagnosis and more effective treatments will enhance the quality...

Clinical Research: Phase 1 - Phase 4

PM360 | New Developments in Gynecological Cancer Research

Substantial unmet needs exist in the diagnosis and treatment of gynecologic cancers. Often, these tumors are detected in later stages when treatment options are limited, and prognosis is poor. However, the gynecologic cancer space is on the cusp of change. The recent introduction of novel medicines, namely targeted therapies, has improved patient care and outcome....

Clinical Research: Phase 1 - Phase 4

The Role of Maintenance Therapy in Gynecologic Cancer Treatment

Advanced ovarian and endometrial carcinomas present the greatest challenge in treating gynecologic cancer and, among the five types of female cancers, are responsible for the most U.S. deaths annually.1 With a combination of surgery, chemotherapy, and radiation; patients can go into remission, but the majority will have a recurrence after several months or years. There...

Clinical Research: Phase 1 - Phase 4

Challenges and Opportunities in Gynecologic Cancer Research: Excerpts from a Round Table Discussion

Gynecologic cancers are comprised of five major types: ovarian, uterine, cervical, vaginal, and vulvar. All women are at risk for these, and risk increases with age. Specific risk factors include a family history, human papillomavirus (HPV) infections (cervical cancer), genetic mutations such as BRCA1 and BRCA2 (ovarian cancer or OC), and hormone replacement therapy. Early...

Clinical Research: Phase 1 - Phase 4

Improving Birth Control for All: Opportunities and Obstacles in Male Contraception

Introduction There are currently more than a dozen categories of female birth control with proven efficacy on the market. For men, the only options available today are condoms and vasectomy. Despite decades of research and discussion about male contraception, no new products have entered the market since the condom was created in the 1800s. As...